Comprehensive Industry Report Offers Forecast and Analysis on Glaucoma Market by 2026 - Novartis AG, Allergan Inc., Merck & Co., Akron Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer Inc., Santen

Overview: -

Glaucoma is the second most common leading cause of blindness and is commonly observed in the older population. This disease damages the optic nerve, which happens due to extra fluid that is built in front of eye, resulting in increased pressure on eye. Glaucoma is generally characterized by symptoms such as tunnel vision, eye pain, blurred vision, and red eyes.

The clear liquid that is present in and out of anterior chamber nourishes nearby tissue in the eye. Generally, there are two types of glaucoma namely; Primary open-angle glaucoma and angle-closure glaucoma. Primary open-angle glaucoma is the most common type of glaucoma which is found in the iris located very close to the drainage angle in the eye. The treatment of glaucoma majorly focuses on the improving fluid flow in the eyes or reducing its production. Majorly used eye drops include prostaglandin analogues, cholinergic agents, and beta blockers. Even though, with high adoption rate the eye drops have relative side effects that lead to chronic disorders like kidney stone, weight loss, impotence, and fatigue.

Request Sample Pages for more Professional and Technical insights @
http://bit.ly/2zmWuHB

Glaucoma Market is driven by the factors such as increasing geriatric population and increasing demand for the combination drugs by end users.

The growth in Glaucoma Market is primarily driven by the increasing number of fixed-dose combination that are used for treating glaucoma and increasing geriatric population. Additionally, increasing awareness for diagnosis of glaucoma at the initial stage is also resulting in growth of this entire industry. Also, development of new phase drugs by the biopharmaceutical companies and government initiatives for supporting the drug development is expected to increase the market for glaucoma during the forecast period. Moreover, rapid technological advancements in the devices that are used in surgeries would also stimulate the growth of this market.

However, lack of awareness about glaucoma treatment by using various surgical devices across developing countries would impede the growth of Glaucoma Market in the near future.

Key players in the Glaucoma Market are:
• Novartis AG
• Allergan Inc.
• Merck & Co.
• Akron, Inc.
• Bausch & Lomb Incorporated
• Teva Pharmaceuticals
• Pfizer Inc.
• Santen
• Aerie Pharmaceuticals
• Inotek Pharmaceuticals
• Essilor International SA
• Hoya Corporation
• Sonomed Escalon
• Carl Zeiss Meditec AG
• HumanOptics AG

For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2zsri9R

On the basis of geography, North America region is expected to dominate the Glaucoma Market over the forecast period. The primary factor influencing growth of market in this region is rise in observance of glaucoma among the increasing geriatric population. Additionally, availability of key manufacturers and heavy investment on research and development by the government towards glaucoma is expected to have a positive impact on the growth of market in North America. On the other hand, increased awareness for the use of these drugs also promotes market growth in the near future. While, Europe region is observed to hold the second largest market share in this market.

However, Asia Pacific is observed to grow at a faster rate during forecast period. Increasing awareness for the use of new drugs, improving economic settings by the key payers for focussing on the untapped market, and growing government concern for promoting minimal invasive surgeries are the major factors resulting in growth of Glaucoma Market in Asia Pacific during upcoming years.

Table of Content of Glaucoma Market:

Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Glaucoma Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
TOC Continued…...!!!

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.